Article Text

other Versions

PDF
Successful treatment of aortic bio-prosthetic valve failure by transcatheter aortic valve implantation
  1. Jerzy Wojciuk,
  2. Ranjit S More,
  3. David H Roberts
  1. Cardiology Department, Lancashire Cardiac Centre, Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust, Whinney Heys Road, Blackpool, Lancashire, UK
  1. Correspondence to Jerzy Wojciuk, Cardiology Department, Lancashire Cardiac Centre, Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust, Whinney Heys Road, Blackpool, Lancashire FY3 8NR, UK; dr.wojciuk{at}bfwhospitals.nhs.uk

Statistics from Altmetric.com

An 85-year-old man presented acutely with NYHA class IV symptoms requiring continuous intravenous infusion of diuretics over several weeks. Echocardiography showed preserved left ventricular function and a severe central jet of regurgitation through a stented bioprosthetic aortic valve (25 mm Carpentier Edwards, implanted in 1994, Edwards Lifesciences Ltd, Irvine, California, USA) (figure 1A,B, videos 1 and 2). High Euroscore and multiple comorbidities (including chronic cardiac and renal failure) precluded reoperation. Transfemoral transcatheter aortic valve implantation (TAVI) using a self-expanding CoreValve was successfully …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.